A bunch of firms — ranging from a drugmaker to a jeweler — will likely test investor demand over the next few months, helping revive fundraising through first-time sales from the lowest in 4 years
A bunch of firms — ranging from a drugmaker to a jeweler — will likely test investor demand over the next few months, helping revive fundraising through first-time sales from the lowest in 4 years